This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of peptide-based drugs. It serves as a key intermediate in the production of active pharmaceutical ingredients (APIs) that target specific biological pathways. Its structure, featuring a fluorophenyl group and a Boc-protected amino group, makes it valuable for introducing fluorine atoms into peptides, enhancing their stability and bioavailability. Additionally, it is employed in the creation of custom peptides for drug discovery, enabling the study of receptor-ligand interactions and the development of targeted therapies for various diseases, including cancer and neurological disorders.